» Articles » PMID: 35432210

New Insights Into the Interplay Among Autophagy, the NLRP3 Inflammasome and Inflammation in Adipose Tissue

Overview
Specialty Endocrinology
Date 2022 Apr 18
PMID 35432210
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a feature of metabolic syndrome with chronic inflammation in obese subjects, characterized by adipose tissue (AT) expansion, proinflammatory factor overexpression, and macrophage infiltration. Autophagy modulates inflammation in the enlargement of AT as an essential step for maintaining the balance in energy metabolism and waste elimination. Signaling originating from dysfunctional AT, such as AT containing hypertrophic adipocytes and surrounding macrophages, activates NOD-like receptor family 3 (NLRP3) inflammasome. There are interactions about altered autophagy and NLRP3 inflammasome activation during the progress in obesity. We summarize the current studies and potential mechanisms associated with autophagy and NLRP3 inflammasome in AT inflammation and aim to provide further evidence for research on obesity and obesity-related complications.

Citing Articles

NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies.

Chen P, Li X Front Pharmacol. 2024; 15:1430236.

PMID: 39144618 PMC: 11322363. DOI: 10.3389/fphar.2024.1430236.


Cellular Senescence and Extracellular Vesicles in the Pathogenesis and Treatment of Obesity-A Narrative Review.

Liang Y, Kaushal D, Wilson R Int J Mol Sci. 2024; 25(14).

PMID: 39063184 PMC: 11276987. DOI: 10.3390/ijms25147943.


Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies?.

Friuli M, Sepe C, Panza E, Travelli C, Paterniti I, Romano A Front Pharmacol. 2024; 15:1407336.

PMID: 38895630 PMC: 11184060. DOI: 10.3389/fphar.2024.1407336.


Antidepressant pharmacological mechanisms: focusing on the regulation of autophagy.

Lv S, Zhang G, Huang Y, Li J, Yang N, Lu Y Front Pharmacol. 2023; 14:1287234.

PMID: 38026940 PMC: 10665873. DOI: 10.3389/fphar.2023.1287234.


Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC.

Zhao J, Liu H, Hong Z, Luo W, Mu W, Hou X Mol Med. 2023; 29(1):84.

PMID: 37400760 PMC: 10318668. DOI: 10.1186/s10020-023-00671-0.


References
1.
Li Y, Guan W, Ma S, Lin S, Yang N, Liu R . Lipopolysaccharide and inflammatory cytokines levels decreased after sleeve gastrectomy in Chinese adults with obesity. Endocr J. 2019; 66(4):337-347. DOI: 10.1507/endocrj.EJ18-0446. View

2.
Afshin A, Forouzanfar M, Reitsma M, Sur P, Estep K, Lee A . Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017; 377(1):13-27. PMC: 5477817. DOI: 10.1056/NEJMoa1614362. View

3.
Villarroya F, Cereijo R, Gavalda-Navarro A, Villarroya J, Giralt M . Inflammation of brown/beige adipose tissues in obesity and metabolic disease. J Intern Med. 2018; 284(5):492-504. DOI: 10.1111/joim.12803. View

4.
Rheinheimer J, de Souza B, Cardoso N, Bauer A, Crispim D . Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review. Metabolism. 2017; 74:1-9. DOI: 10.1016/j.metabol.2017.06.002. View

5.
Saitoh T, Fujita N, Jang M, Uematsu S, Yang B, Satoh T . Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008; 456(7219):264-8. DOI: 10.1038/nature07383. View